The FDA’s Commissioner’s National Priority Voucher (CNPV) pilot program was announced in June 2025 to reduce review times for drug and biological products down to 1-2 months compared with 6+ months for conventional drug and biological product applications by implementing a “tumor board” style review process. The program was envisioned to expedite review process of…